Ignite Creation Date:
2025-12-17 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 2:52 AM
Study NCT ID:
NCT00787293
Status:
SUSPENDED
Last Update Posted:
2011-02-14
First Post:
2008-11-05
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
Sponsor:
Viacor
Organization:
Study Overview
Official Title:
A Multi-center Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients With Heart Failure
Status:
SUSPENDED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Company ended operations January 2011
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PTOLEMY-2
Brief Summary:
Improvement in heart failure with moderate to severe mitral regurgitation using a percutaneously delivered implantable device.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: